Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects

被引：0
|
作者：
Jacob Atsmon
Jasper Dingemanse
Dimitri Shaikevich
Inna Volokhov
Patricia N. Sidharta
机构：
[1] Tel Aviv Sourasky Medical Center,Clinical Research Center
[2] Tel Aviv University,Tel Aviv Sackler Faculty of Medicine
[3] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
来源：
Clinical Pharmacokinetics | 2013年 / 52卷
关键词：
Pulmonary Arterial Hypertension; Ketoconazole; Bosentan; Terfenadine; Saquinavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：685 / 692
页数：7
相关论文
共 50 条
  • [1] Investigation of the Effects of Ketoconazole on the Pharmacokinetics of Macitentan, a Novel Dual Endothelin Receptor Antagonist, in Healthy Subjects
    Atsmon, Jacob
    Dingemanse, Jasper
    Shaikevich, Dimitri
    Volokhov, Inna
    Sidharta, Patricia N.
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 685 - 692
  • [2] Pharmacokinetics of the Novel Dual Endothelin Receptor Antagonist Macitentan in Subjects With Hepatic or Renal Impairment
    Sidharta, Patricia N.
    Lindegger, Nicolas
    Ulc, Ivan
    Dingemanse, Jasper
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (03): : 291 - 300
  • [3] PHARMACOKINETICS, TOLERABILITY, AND SAFETY OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN JAPANESE AND CAUCASIAN HEALTHY SUBJECTS
    Bruderer, S.
    Marjason, J.
    Sidharta, P.
    Dingemanse, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S83 - S83
  • [4] Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Wolzt, Michael
    Dingemanse, Jasper
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1035 - 1042
  • [5] MACITENTAN, A NOVEL DUAL ENDOTHELIN RECEPTOR ANTAGONIST, DOES NOT PROLONG THE QT/QTC INTERVAL IN A THOROUGH QTC STUDY IN HEALTHY SUBJECTS
    Sidharta, P. N.
    Lindegger, N.
    Reseski, K.
    Dingemanse, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S108 - S109
  • [6] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    Sidharta, P. N.
    Treiber, A.
    Dingemanse, J.
    [J]. CLINICAL PHARMACOKINETICS, 2015, 54 (05) : 457 - 471
  • [7] Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
    P. N. Sidharta
    A. Treiber
    J. Dingemanse
    [J]. Clinical Pharmacokinetics, 2015, 54 : 457 - 471
  • [8] Lack of relevant pharmacokinetic interactions between the new dual endothelin receptor antagonist macitentan and sildenafil in healthy subjects
    Sidharta, Patricia
    van Giersbergen, Paul
    Wolzt, Michael
    Dingemanse, Jasper
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist
    Nami, Majid
    Sovari, Sara Nasiri
    Haghighatnia, Yaghoub
    Dabiri, Minoo
    Salehi, Peyman
    [J]. ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2017, 49 (03) : 258 - 264
  • [10] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of macitentan, an Endothelin Receptor Antagonist, in an Ascending Multiple-Dose Study in Healthy Subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Dingemanse, Jasper
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (11): : 1131 - 1138
12345